CytomX

This page shows the latest CytomX news and features for those working in and with pharma, biotech and healthcare.

Amgen pledges $1.5bn for CytomX preclinical cancer drugs

Amgen pledges $1.5bn for CytomX preclinical cancer drugs. Stellar valuations for immuno-oncology candidates continue. ... Shares in US clinical stage biopharmaceutical company CytomX leaped more than a third on the latest deal.

Latest news

BMS taps F-star Alpha for immuno-oncology drug

MD Anderson Cancer Centre in the US, as well as earlier collaborations with InCyte and CytoMx.
Pfizer signs $635m deal with CytomX for cancer ADCs

Pfizer signs $635m deal with CytomX for cancer ADCs. Will use biotech's Probody technology to develop antibody-drug conjugates. ... The mask is designed to be removed in the presence of an enzyme that is found only in diseased cells, says CytomX.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Deal Watch March 2017

BMS has expanded its 2014 agreement with CytomX Therapeutics to access up to eight further targets in oncology and other fields, using CytomX’s Probody platform. ... 650. CytomX Therapeutics. BMS. Strategic collaboration. Probody platform to enhance
Deal Watch April 2016

CytomX leads. Argenx undertakes R&D until IND, AbbVie thereafter it option exercised. ... Zymeworks, like CytomX, have multiple Big Pharma partners including Merck &Co and Lilly.
Pharma deals during May 2014

BMS also entered into a platform deal with CytomX for so-called “ Probodies,” monoclonal antibodies that are selectively activated within the cancer microenvironment.
Deal Watch table for May 2014

CytomX / BMS. Development and commercialisation licence. Selective monoclonal antibodies (“ Probodies”) for up to 4 oncology targets.
Deal Watch table for June 2013

818. CytomX / Pfizer. Collaboration and exclusive licence to selected PDCs.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

CytomX appoints Rachel Humphrey chief medical officer

CytomX appoints Rachel Humphrey chief medical officer. Former VP of Eli Lilly and AstraZeneca joins the company. ... She said: “ Since joining the CytomX board of directors in March, I have been able to see at first-hand the tremendous power of the
CytomX makes senior changes following Pfizer deal

CytomX Therapeutics has boosted both its senior science and business teams following a major antibody deal with Pfizer. ... His new colleague Ray joined CytomX in 2011 and was instrumental in brokering the agreement with Pfizer.

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Medical Writer: Salary is DOE

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Account Manager- 4 days per week or full-time: Salary TBC

Market Access Consultant - Greater Manchester: Negotiable

Senior Training Manager - Surrey: Competitive Salary &Bonus

Healthcare PR Senior Account Manager: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Systematic Review Lead- London: Negotiable

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Senior Writer, Healthcare Advertising, London: Excellent package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Medical Writer - Creative and Scientific Projects: DOE

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Sudler London - Account Director: Competitive

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Senior Medical Writer, MedComms Agency: Salary TBC

Graduate Scientific Editor: DOE

Subscribe to our email news alerts

PMHub

Add my company

CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....